Search Browse Earnings

Profound Medical Corp.

Nasdaq:PROF

Surgical & Medical Instruments & Apparatus·MISSISSAUGA, A6

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Profound Medical Corp. — SlamSEC

Revenue

$5.9M

FY 2024

Adj. EBITDA

-$32.4M

-548.5% margin

FY 2025

Net Income

-$27.8M

-471.5% margin

FY 2025

EPS (Diluted)

$1.12

FY 2025

Stock Price

$5.31

2026-03-06

52W Range

—

P/E Ratio

4.7x

Market Cap

$192.7M

Cash

$54.9M

FY 2025

Total Debt

$2.9M

FY 2025

Net Cash

$52.0M

FY 2025

Enterprise Value

$140.7M

Debt / EBITDA

1.6x

FY 2024

EV / EBITDA

-4.3x

Employees

—